• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化伴低钠血症患者住院死亡率的预测模型:人工神经网络方法。

Predictive model of in-hospital mortality in liver cirrhosis patients with hyponatremia: an artificial neural network approach.

机构信息

Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Shenyang Pharmaceutical University), Shenyang, China.

Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.

出版信息

Sci Rep. 2024 Nov 20;14(1):28719. doi: 10.1038/s41598-024-73256-4.

DOI:10.1038/s41598-024-73256-4
PMID:39567595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11579295/
Abstract

Hyponatremia can worsen the outcomes of patients with liver cirrhosis. However, it remains unclear about how to predict the risk of death in cirrhotic patients with hyponatremia. Patients with liver cirrhosis and hyponatremia were screened. Eligible patients were randomly divided into the training (n = 472) and validation (n = 471) cohorts. In the training cohort, the independent predictors for in-hospital death were identified by logistic regression analyses. Odds ratios (ORs) were calculated. An artificial neural network (ANN) model was established in the training cohort. Areas under curve (AUCs) of ANN model, Child-Pugh, model for end-stage liver disease (MELD), and MELD-Na scores were calculated by receiver operating characteristic curve analyses. In multivariate logistic regression analyses, ascites (OR = 2.705, P = 0.042), total bilirubin (OR = 1.004, P = 0.003), serum creatinine (OR = 1.004, P = 0.017), and international normalized ratio (OR = 1.457, P = 0.005) were independently associated with in-hospital death. Based on the four variables, an ANN model was established. Its AUC was 0.865 and 0.810 in the training and validation cohorts, respectively, which was significantly larger than those of Child-Pugh (AUC = 0.757), MELD (AUC = 0.765), and MELD-Na (AUC = 0.769) scores. An ANN model has been developed and validated for the prediction of in-hospital death in patients with liver cirrhosis and hyponatremia.

摘要

低钠血症可使肝硬化患者的预后恶化。然而,对于低钠血症的肝硬化患者如何预测死亡风险仍不清楚。筛选出肝硬化伴低钠血症的患者。将符合条件的患者随机分为训练组(n=472)和验证组(n=471)。在训练组中,通过逻辑回归分析确定住院死亡的独立预测因素。计算比值比(ORs)。在训练组中建立人工神经网络(ANN)模型。通过受试者工作特征曲线分析计算 ANN 模型、Child-Pugh、终末期肝病模型(MELD)和 MELD-Na 评分的曲线下面积(AUCs)。在多变量逻辑回归分析中,腹水(OR=2.705,P=0.042)、总胆红素(OR=1.004,P=0.003)、血清肌酐(OR=1.004,P=0.017)和国际标准化比值(OR=1.457,P=0.005)与住院期间死亡独立相关。基于这四个变量,建立了一个 ANN 模型。其在训练组和验证组中的 AUC 分别为 0.865 和 0.810,明显大于 Child-Pugh(AUC=0.757)、MELD(AUC=0.765)和 MELD-Na(AUC=0.769)评分。已经开发并验证了一种 ANN 模型,用于预测肝硬化伴低钠血症患者的住院期间死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e569/11579295/5d8351fbb993/41598_2024_73256_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e569/11579295/d5dfae3b375c/41598_2024_73256_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e569/11579295/5d8351fbb993/41598_2024_73256_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e569/11579295/d5dfae3b375c/41598_2024_73256_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e569/11579295/5d8351fbb993/41598_2024_73256_Fig2_HTML.jpg

相似文献

1
Predictive model of in-hospital mortality in liver cirrhosis patients with hyponatremia: an artificial neural network approach.肝硬化伴低钠血症患者住院死亡率的预测模型:人工神经网络方法。
Sci Rep. 2024 Nov 20;14(1):28719. doi: 10.1038/s41598-024-73256-4.
2
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.持续性腹水和低血钠可识别出肝硬化且终末期肝病模型(MELD)评分低但早期死亡风险高的患者。
Hepatology. 2004 Oct;40(4):802-10. doi: 10.1002/hep.20405.
3
Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.终末期肝病评分与血清钠比值指数模型作为肝硬化患者预后预测指标的验证
J Gastroenterol Hepatol. 2009 Sep;24(9):1547-53. doi: 10.1111/j.1440-1746.2009.05913.x. Epub 2009 Aug 3.
4
Development and Validation of CAGIB Score for Evaluating the Prognosis of Cirrhosis with Acute Gastrointestinal Bleeding: A Retrospective Multicenter Study.CAGIB 评分用于评估急性胃肠道出血伴肝硬化患者预后的开发和验证:一项回顾性多中心研究。
Adv Ther. 2019 Nov;36(11):3211-3220. doi: 10.1007/s12325-019-01083-5. Epub 2019 Sep 11.
5
The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.终末期肝病钠模型(Refit model for end-stage liver disease-Na)并不优于终末期肝病模型(Refit model for end-stage liver disease)预测肝硬化伴腹水患者的死亡率。
Clin Mol Hepatol. 2014 Mar;20(1):47-55. doi: 10.3350/cmh.2014.20.1.47. Epub 2014 Mar 26.
6
Artificial neural network-based models used for predicting 28- and 90-day mortality of patients with hepatitis B-associated acute-on-chronic liver failure.基于人工神经网络的模型用于预测乙型肝炎相关慢加急性肝衰竭患者 28 天和 90 天死亡率。
BMC Gastroenterol. 2020 Mar 13;20(1):75. doi: 10.1186/s12876-020-01191-5.
7
A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.肝硬化患者不同预后模型的修订范围:当前与未来展望,埃及的经验
Arab J Gastroenterol. 2013 Dec;14(4):158-64. doi: 10.1016/j.ajg.2013.08.007. Epub 2013 Sep 29.
8
Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.终末期肝病模型或许优于其他基于终末期肝病模型的系统,包括 Child-Turcotte-Pugh 评分和白蛋白-胆红素评分,在乙型肝炎病毒相关性肝硬化和自发性细菌性腹膜炎患者中。
Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1256-1263. doi: 10.1097/MEG.0000000000001481.
9
Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.用于肝硬化合并胃肠道出血患者风险分析的包含校正 QT 间期的评分系统的建立与验证。
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1388-1397.e1. doi: 10.1016/j.cgh.2018.12.006. Epub 2018 Dec 15.
10
Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study.白蛋白-胆红素评分预测肝硬化急性上消化道出血患者院内死亡率的回顾性研究
Turk J Gastroenterol. 2016 Mar;27(2):180-6. doi: 10.5152/tjg.2016.15502.

引用本文的文献

1
28-day all-cause mortality in patients with alcoholic cirrhosis: a machine learning prediction model based on the MIMIC-IV.酒精性肝硬化患者的28天全因死亡率:基于MIMIC-IV的机器学习预测模型
Clin Exp Med. 2025 Jun 11;25(1):198. doi: 10.1007/s10238-025-01744-6.
2
Development and application of an early warning model for predicting early mortality following stent placement in malignant biliary obstruction: A comparative analysis of logistic regression and artificial neural network approaches.恶性胆道梗阻支架置入术后早期死亡预测预警模型的开发与应用:逻辑回归与人工神经网络方法的对比分析
Oncol Lett. 2025 Mar 20;29(5):237. doi: 10.3892/ol.2025.14983. eCollection 2025 May.
3

本文引用的文献

1
Artificial Intelligence and Machine Learning in Clinical Medicine, 2023.临床医学中的人工智能与机器学习,2023年。
N Engl J Med. 2023 Mar 30;388(13):1201-1208. doi: 10.1056/NEJMra2302038.
2
How can artificial neural networks approximate the brain?人工神经网络如何模拟大脑?
Front Psychol. 2023 Jan 9;13:970214. doi: 10.3389/fpsyg.2022.970214. eCollection 2022.
3
Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis.短期输注人白蛋白对肝硬化患者低钠血症的防治作用
The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC.
EZ-ALBI评分和PALBI评分有助于ALBI在预测肝癌术后复发方面的临床应用。
Sci Rep. 2025 Mar 17;15(1):9132. doi: 10.1038/s41598-025-93716-9.
J Clin Med. 2022 Dec 23;12(1):107. doi: 10.3390/jcm12010107.
4
Predictors of Death in the Liver Transplantation Adult Candidates: An Artificial Neural Networks and Support Vector Machine Hybrid-Based Cohort Study.成人肝移植候选者死亡的预测因素:一项基于人工神经网络和支持向量机混合模型的队列研究。
J Biomed Phys Eng. 2022 Dec 1;12(6):591-598. doi: 10.31661/jbpe.v0i0.2010-1212. eCollection 2022 Dec.
5
A model to predict inhospital mortality in patients with cirrhosis, ascites and hyponatremia.一种预测肝硬化、腹水和低钠血症患者住院死亡率的模型。
Eur J Gastroenterol Hepatol. 2022 Jun 1;34(6):591-597. doi: 10.1097/MEG.0000000000002357. Epub 2022 Feb 14.
6
Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases.人工智能在结直肠癌肝转移的诊断和管理中的应用。
World J Gastroenterol. 2022 Jan 7;28(1):108-122. doi: 10.3748/wjg.v28.i1.108.
7
Peripheral Blood Cell Ratios as Prognostic Predictors of Mortality in Patients with Hepatitis B Virus-Related Decompensated Cirrhosis.外周血细胞比值作为乙型肝炎病毒相关性失代偿期肝硬化患者死亡的预后预测指标。
Clin Lab. 2021 Dec 1;67(12). doi: 10.7754/Clin.Lab.2021.210238.
8
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.MELD 3.0:适应新时代的终末期肝病模型。
Gastroenterology. 2021 Dec;161(6):1887-1895.e4. doi: 10.1053/j.gastro.2021.08.050. Epub 2021 Sep 3.
9
Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery.人工智能、大数据和机器学习方法在精准医学和药物发现中的应用。
Curr Drug Targets. 2021;22(6):631-655. doi: 10.2174/1389450122999210104205732.
10
Hyponatremia in Cirrhosis: An Update.肝硬化伴低钠血症:最新进展。
Am J Gastroenterol. 2020 Nov;115(11):1775-1785. doi: 10.14309/ajg.0000000000000786.